[1]
Juniar, S.D., Alsagaff, M.Y., Pikir, B.S. and Lestari, P. 2022. Dapagliflozin Use in Heart Failure with Reduced Ejection Fraction Accompanied by Type 2 Diabetes Mellitus: A Systematic Review. Cardiovascular and Cardiometabolic Journal (CCJ). 3, 1 (Mar. 2022), 60–74. DOI:https://doi.org/10.20473/ccj.v3i1.2022.60-74.